Loading…
CIK 0001776382 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("venbio-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACELYRIN INC | COM | $9.4M | 7.6% | 3,806,410 SH | |
| ALUMIS INC | COM | $17.1M | 13.9% | 2,787,398 SH | |
| ALX ONCOLOGY HLDGS INC | COM | $6.0M | 4.9% | 9,699,925 SH | |
| ARTIVA BIOTHERAPEUTICS INC | COM | $3.6M | 2.9% | 1,198,975 SH | |
| HARMONY BIOSCIENCES HLDGS IN | COM | $16.2M | 13.1% | 489,194 SH | |
| LYELL IMMUNOPHARMA INC | COM | $3.8M | 3.1% | 7,102,190 SH | |
| PHARVARIS N V | COM | $67.3M | 54.5% | 4,289,304 SH |
| 13F-HR |
| 0000905148-26-003741 |
| $519.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002929 | $114.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002409 | $280.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000905148-25-001748 | $123.6M | View |